ABSTRACT. We investigated whether cationic liposomes are efficient at delivering the gene for diphtheria toxin A-chain (DT-A) under the control of the long terminal repeat (LTR) of bovine leukemia virus (BLV) (pLTR-DT) into BLV-infected cells and are also suitable for in vivo use. The transfection activity of the cationic liposomes composed of N-(α-trimethylammonioacetyl)-didodecyl-D-glutamate chloride (TMAG), dioleoyl phosphatidylethanolamine (DOPE) and dilauroyl phosphatidylcholine (DLPC) (1:2:2, molar ratio) (TMAG-liposome) and liposomes composed of phosphatidylserine (PS) (PS-liposome) was evaluated by the luciferase assay using a plasmid which contains the coding sequence of firefly luciferase under the control of the SRα promoter (pSRα/L-A∆5). The TMAG-liposome gave highly efficient transfection in the presence of serum. On the other hand, PS-liposome showed inferior efficiency. When BLV-infected cells were co-transfected with a fixed amount of pSRα/L-A∆5-entrapped TMAG-liposome and various amount of pLTR-DT-containing TMAGliposome, the luciferase activity in the BLV-infected cells was inhibited by the addition of pLTR-DT-entrapped TMAG-liposome dosedependently. The cationic TMAG-liposome containing pLTR-DT was successively added to BLV-infected cells in culture. The number of viable cells was markedly reduced by the cationic TMAG-liposome containing pLTR-DT. On the other hand, TMAG-liposome containing pSRα/L-A∆5 showed no such effect. pLTR-DT entrapped by the cationic TMAG-liposome was not digested by the treatment with DNase I and with serum. These results suggest that the cationic liposomes, such as TMAG-liposome, may be efficient transfection reagent for the BLV-infected cells and can be utilized for DT-A gene delivery into the BLV-infected cells in vivo. -KEY WORDS: bovine leukemia virus, cationic liposomes, diphtheria toxin, gene therapy, liposomes.
materials are protected from enzymatic attack until they reach the target sites. Recently, liposomes have been used for in vitro gene transfer in the cells in culture [2, 5, 6] . However, the greatest potentiality for liposomes-mediated gene transfer seems to lie in its in vivo applications. The potential usefulness of liposomes as a carrier for gene transfer has attracted considerable interest during the last few years [1, 3, 4, 6, 15, 20] . In particular, positively charged liposomes, which are composed of cationic lipid, are regarded as an efficient tool for gene transfer into cells, because liposomes containing cationic lipids are more efficient in transfection compared to liposomes containing no positively charged lipid [2, 9, 10] , though the transfection efficiency of positively charged liposomes depends on the cells used [10] . This finding prompted us to investigate whether cationic liposomes are efficient at delivering pLTR-DT into BLV-infected cells and are suitable for in vivo use.
In this paper, we investigate the delivery of the gene for DT-A in BLV-infected cells using cationic liposomes containing N-(α-trimethylammonioacetyl)-didodecyl-Dglutamate chloride (TMAG). We found that positively charged liposomes containing TMAG deliver more effectively than liposomes composed of PS in the presence of serum, and that the number of viable BLV-infected cells is markedly reduced by treatment with pLTR-DT-containing cationic liposomes. In addition, the pLTR-DT entrapped by cationic liposomes is little affected by treatment with DNase Enzootic bovine leukosis (EBL) is a lymphoproliferative disease caused by bovine leukemia virus (BLV) [12] . BLV induces both lymphocytosis, which is characterized by an increased number of B lymphocytes in the peripheral blood [17] , and lymphosarcoma in various lymph nodes in a later stage. One of the most characteristic features of this virus is that the viral genome encodes a specific transcriptional activator called p34 [13, 18] , as is the case with human Tcell leukemia virus (HTLV) type I and II [19] . The transactivation by p34 is assumed to be mandatory for the promoter activity of the long terminal repeat (LTR) of BLV (BLV-LTR), and hence the expression of viral genes. We previously demonstrated that the promoter activity of BLV-LTR proved to be highly specific to the BLV-infected cells, and that the formation of syncytium induced by BLVinfected cells was effectively suppressed by the phosphatidylserine (PS) liposomes containing the gene for diphtheria toxin A-chain (DT-A) under the control of BLV-LTR (pLTR-DT) [6] .
Liposomes are bilayer vesicles composed of amphiphilic phospholipids. They are non-toxic, biodegradable and poorly immunogenic. Furthermore, the liposomes-entrapped I and serum. These findings indicate that cationic liposomes entrapping pLTR-DT may have potential usefulness for gene therapy of bovine leukosis. The present data will also be useful in the research of gene delivery in vitro and in vivo to cells.
MATERIALS AND METHODS

Materials: N-(α-trimethylammonioacetyl)-didodecyl-D-
glutamate chloride (TMAG) was gifted from Sogo P h a r m a c e u t i c a l C o . , L t d . , T o k y o ; d i o l e o y l phosphatidylethanolamine (DOPE) was purchased from Avanti Polar Lipids, Birmingham, AL; dilauroyl phosphatidylcholine (DLPC) from Sigma Chemical Co., (Sigma chemical Co., St. Louis, Mo, U.S.A.); 4, 6-diamidino-2-phenylindole (DAPI) from Nacalai Tesque, Inc., Kyoto. Phosphatidylserine (PS) was purified from bovine brain [5] . Plasmids pSRα/L-A∆5, (a gift from Dr. Y. Takebe, National Institute of Health Japan, Tokyo), which allows the expression of firefly luciferase driven by the SRα promoter, and pLTR-DT [6] were amplified in Escherichia coli JM 109 and purified by cesium chloride gradient centrifugation method.
Cells: Fetal lamb kidney (FLK) cells chronically infected with and producing BLV (FLK/BLV) and C8 cells, which are one of the mouse sarcoma virus-transformed feline cell lines, were used for the transfection. Cells were maintained in Eagle's minimal essential medium (MEM) (Nissui Pharmaceutical Co., Ltd., Tokyo, Japan) supplemented with 10% fetal calf serum (FCS) and antibiotics.
Preparation of liposomes: Cationic liposomes entrapping plasmids were prepared as follows: TMAG (0.05 µmol), DLPC (0.1 µmol), and DOPE (0.1 µmol) were each dissolved in chloroform-methanol (2:1, v/v) then mixed in a conical flask. After evaporation of the solvents by a rotary evaporator and by a vacuum pump, 125 µl of sterilized phosphate-buffered saline (PBS; pH 7.2) containing 10 µg of plasmids was added. Then, the lipid film was vortexed for a few minutes. Untrapped plasmids were removed by centrifugation at 11,000 × g for 5 min.
The encapsulation of plasmids in large unilamellar vesicles (LUV) composed of PS was performed according to the procedure previously described [5] . PS (5 µmol) was transferred to a conical flask. The lipid was dried on a rotary evaporator, then stood standing for 30 min under vacuum in a desiccator. After addition of 1 ml of sterilized PBS and incubation at 50°C for 1 min, the lipid film was dispersed by vortexing, and sonicated with a probe-type sonicator (Branson sonifier 250, Branson Sonic Power Co., Danbury, CT, U.S.A.) at 20 W for 5 min. One-fifth of the resultant suspension (200 µl) containing 1 µmol of PS was transferred to an Eppendorf microtube, mixed with 200 µl Tris-buffered saline (TBS) [10 mM Tris-HCl (pH 7.6), 145 mM NaCl] containing 20 mM CaCl 2 , and then incubated for 1 hr at 37°C. The suspension was centrifuged at 2,000 × g for 5 min to collect the pellet. DNA (2 µg) was added to the pellet and mixed by tapping followed by incubation for 10 min at 37°C. Then 200 µl of TBS containing 30 mM ethylenediaminetetraacetic acid (EDTA) was added to the microtube, gently mixed, and the suspension was further incubated for 30 min at 37°C. After that, uncapsulated DNA was removed by centrifugation at 8,000 × g for 5 min. DNA entrapped PS liposomes were washed with PBS containing 2 mM MgCl 2 , and used for the experiment.
DNA determination: The amount of DNA entrapped in liposomes was determined by the method described previously [9] : 200 µl of 1.5 M NaCl/30 mM EDTA (pH 8.0) was added to a 20 µl suspension of liposome-entrapped plasmids or standard DNA solution containing 0.5-2 µg of DNA, followed by vortex mixing. The resulting solutions were mixed with 300 µl of a mixture of chloroform and methanol (2:1, v/v). After centrifugation at 11,000 × g for 5 min, the aqueous phase (200 µl) was mixed with 1 ml of 10 mM Tris-HCl buffer (pH 7.0) containing 100 ng/ml DAPI, 100 mM NaCl and 100 mM EDTA, and the fluorescence of DNA-DAPI complexes was subsequently measured at 450 nm with excitation at 360 nm with a Hitachi fluorescence spectrophotometer F-3010 (Hitachi Co., Ltd., Tokyo, Japan).
Liposomes-mediated transfection: FLK/BLV cells were seeded at a density of 1 × 10 5 cells per well in 24 well plate (Corning Inc., Corning, NY) and cultured for 24 hr at 37°C. After cultivation, the medium was removed, and DNAcontaining liposomes were added to the cells. Then, 1 ml of medium supplemented with 10% FCS was added and then cultured. After 48 hr cultivation at 37°C, cells were harvested and used for luciferase assay.
Luciferase assay: Transfection efficiency was evaluated by the luciferase assay using pSRα/L-A∆5. After 48 hr of incubation, the cells were washed 3 times with PBS, covered with 50 µl of cell culture lysis reagent (25 mM Trisphosphate, pH 7.8, containing 2 mM dithiothreitol, 2 mM 1,2-diaminocyclohexane-N,N,N',N'-tetraacetic acid, 10% glycerol, and 1% Triton X-100), and incubated for 15 min at room temperature. The cell suspension was centrifuged briefly in a microcentrifuge (700 × g, 3 min). The supernatant was then subjected to the assay for luciferase activity and protein quantitative analysis.
The enzymatic activity of luciferase was measured using luciferase assay system kit (Promega Co., Madison, WI, U.S.A.) as follows: 100 µl of luciferase assay reagent [20 mM Tricine, 1.07 mM (MgCO 3 ) 4 Mg(OH) 2 ·5H 2 O, 2.67 mM MgSO 4 , 0.1 mM EDTA, 33.3 mM dithiothreitol, 270 µM coenzyme A, 470 µM luciferin, and 530 µM ATP] to 15 µl of the supernatant in a 96 well microplate (MS-8496K, Sumitomo Bakelite, Tokyo, Japan). Integrated light output was measured for 1 min with a Micro Lumino Reader (CORONA MLR-100, Corona Electric Co., Ltd., Hitachinaka, Japan). Luciferase activity was expressed as "unit/µg protein/min".
The protein concentration of the cell lysate was quantitated using a Bio-Rad protein assay kit (Bio-Rad Laboratories, Richmond, CA, U.S.A.) and bovine plasma gamma globulin was used as a standard.
Treatment of pLTR-DT-entrapped TMAG-liposome with
DNase I and serum: One µg of pLTR-DT plasmids and pLTR-DT-entrapped TMAG-liposome were incubated with 1 unit of DNase I (Stratagene, MI, U.S.A.) in the presence of 10 mM Tris-HCl buffer (pH 7.5) containing 10 mM MgCl 2 , 10 mM CaCl 2 , and 50% (v/v) glycerol, or with an equal volume of FCS, at 37°C for 1 hr. After that, solutions were mixed with an equal volume of a mixture of phenolchloroform (1:1, v/v) and vortexed for a few minutes, and the mixture was centrifuged at 7,500 × g for 10 min. After phase separation, the upper phase was transferred to an Eppendorf microtube, then 2 volumes of ice-cold 99.5% ethanol were added to the microtube and mixed by vortexing followed by centrifugation at 11,000 × g for 20 min. The pellet was mixed with 10 µl of the sterile distilled water and analyzed by electrophoresis on a 0.8% agarose gel in Trisacetate/EDTA electrophoresis buffer (40 mM Tris base, 1 mM EDTA, and 1.142 % CH 3 COOH; pH 7.6).
RESULTS
Effect of lipid composition of liposomes on transfection activity:
We studied the effect of lipid composition of liposomes on gene transfer in the presence of serum. The transfection activity of TMAG-and PS-liposome was evaluated by the luciferase assay using pSRα/L-A∆5. The result obtained is shown in Fig. 1 .
The cationic MLV composed of TMAG, DOPE and DLPC in a molar ratio of 1:2:2 gave highly efficient transfection into FLK/BLV cells. On the other hand, the transfection activity of the liposomes composed of PS, which have been used for in vitro gene transfer in eukaryotic cells in culture, was lower than that of the cationic liposomes containing TMAG; the activity was 5-fold less active than the TMAG-containing cationic lipsomes. This result suggests that the cationic TMAG-liposome is able to transfer genes efficiently into FLK/BLV cells.
Effect of pLTR-DT-entrapped TMAG-liposome on BLVinfected FLK cells:
In order to examine whether BLV-infected cells are killed by pLTR-DT-entrapped TMAG-liposome, FLK/BLV cells were co-transfected with a fixed amount (0.8 µg) of pSRα/L-A∆5-containing TMAGliposome and various amounts of pLTR-DT-containing TMAG-liposome.
As shown in Fig. 2 , by increasing the amount of pLTR-DT-entrapped TMAG-liposome, luciferase activity in the FLK/BLV cells was drastically inhibited. That is to say, treatment with TMAG-liposome containing pLTR-DT resulted in 1.7, 53.1, 66.5, and 99.9 % inhibition of luciferase activity at concentrations of 0.1, 0.5, 1.0, and 2.0 µg, respectively. However, BLV-uninfected cells, C8 cells, showed luciferase activity under conditions where transfection with TMAG-liposome containing pLTR-DT resulted in the suppression of luciferase activity (data not shown).
Furthermore, the effect of successive treatment of FLK/ BLV cells with pLTR-DT-entrapped TMAG-liposome was studied. In this experiment, FLK/BLV cells were treated with liposomes containing 0.8 µg of pLTR-DT or pSRα/L-A∆5 at times 12, 24, and 36 hr. At times 24, 36, and 48 hr, the number of viable cells was counted.
As shown in Fig. 3 , the number of viable cells was markedly reduced by the treatment with pLTR-DTentrapped TMAG-liposome. On the other hand, TMAG-liposome containing pSRα/L-A∆5 plasmids with a luciferase gene instead of pLTR-DT did not offer any inhibitory effect on the growth of FLK/BLV cells. These results suggest that TMAG-liposome was not toxic to the BLV-infected cells, and that FLK/BLV cells were effectively killed when the pLTR-DT was incorporated into the cells by the cationic TMAG-liposome.
Effect of DNase I and serum on pLTR-DT-entrapped TMAG-liposome:
In order to investigate the effect of DNase I and serum on the pLTR-DT-entrapped TMAG liposome, TMAG-liposome containing pLTR-DT was treated with DNase I and with serum. Result is shown in Fig. 4 .
After treatment with DNase I and with serum, free (unentrapped) pLTR-DT was digested. However, pLTR-DT entrapped by the cationic TMAG-liposome was not digested by the treatment with DNase I and with serum. This finding indicates that the liposome-entrapped pLTR-DT is protected from enzymatic attack, and also that the use of positive charged liposomes (TMAG-liposome) is an efficient tool for the gene transfer into the cells in vivo.
DISCUSSION
The potential usefulness of liposomes as a carrier for gene transfer has attracted considerable interest during the last few years [1, 3, 4, 6, 15, 20] . Especially, positively charged liposomes composed of cationic lipid are regarded as an efficient tool for gene transfer into cells, because liposomes containing cationic lipid are more efficient in transfection when compared with liposomes containing no positively charged lipid [2, 9, 10] . However, the transfection efficiency of cationic liposomes depends on the cell lines used [10] . In the present study, we investigated whether cationic liposomes are efficient at delivering the gene into BLV-infected cells and suitable for in vivo use.
In this study, the cationic liposomes composed of TMAG, DOPE and DLPC (1:2:2, molar ratio) gave highly efficient transfection in the presence of serum. On the other hand, liposomes composed of PS showed inferior efficiency (Fig.  1) . This indicates that the transfection efficiency of the Fig.4 . Agarose gel electrophoretic analysis of pLTR-DT extracted from TMAG-liposome after treatment with DNase I and serum. pLTR-DT plasmids and liposome-entrapped pLTR-DT were recovered after treatment with DNase I and serum as described in "MATERIALS AND METHODS" and subjected to a 0.8% agarose gel electrophoresis. The plasmid DNA was visualized with ethidium bromide and UV light. 1, standard, λDNA/HindIII; 2, standard, pLTR-DT; 3, 1 µg of pLTR-DT was treated with 1 unit of DNase I; 4, 1 µg of pLTR-DT-entrapped TMAG-liposome was treated with 1 unit of DNase I; 5, 1 µg of pLTR-DT was treated with FCS; 6, 1 µg of pLTR-DT-entrapped TMAG-liposome was treated with FCS. liposomes is affected by the lipid composition, and that positively charged TMAG-liposome is more efficient in transfection than liposomes containing PS. In addition, the fact that the transfection activity of the liposomes composed of PS, a negatively charged lipid, was lower than that of the cationic TMAG-liposome suggests the importance of the electrostatic interaction between the negatively charged cell surface and the positively charged surface of the liposomal membrane for the transfection. Indeed, in this experiment, liposomes containing TMAG with strongly positive charges [9, 20] were able to transfer genes efficiently into FLK/ BLV cells in the presence of serum. Previously, we reported that the inhibitory effect of the PS liposomes containing pLTR-DT on BLV-induced syncytium formation [6] . Therefore, we examined the suppressive effect of pLTR-DT-entrapped TMAG-liposome on the growth of FLK/BLV cells. In this study, the luciferase activity in the FLK/BLV cells was inhibited by the addition of pLTR-DT-entrapped TMAG-liposome dosedependently (Fig. 2) . Furthermore, although pSRα/ L-A∆5-entrapped TMAG-liposome did not affect the growth of FLK/BLV cells, the growth of FLK/BLV cells was highly suppressed by the successive transfection with pLTR-DTentrapped TMAG-liposome (Fig. 3) . These results may be attributed to the decrease in the number of FLK/BLV cells by production of diphtheria toxin in such cells, since pLTR-DT works only in BLV-infected cells [6] . Indeed, C8 cells showed luciferase activity under conditions where transfection with TMAG-liposome containing pLTR-DT resulted in the suppression of luciferase activity (data not shown). Moreover, it is noteworthy that in the presence of serum, TMAG-liposome was able to transfect the plasmid DNA into the cells. This suggests that cationic liposomes, i.e., TMAG-liposomes, may be efficient transfection reagents for BLV-infected cells in vivo as well.
Liposomes have been used for in vitro gene transfer in eukaryotic cells in culture [2, 5, 6] . However, the greatest potentiality for liposomes-mediated gene transfer seems to lie in its in vivo applications. In this study, pLTR-DT entrapped by the cationic TMAG-liposome was not digested by the treatment with DNase I and serum, while free (unentrapped) pLTR-DT was digested after treatment with DNase I and serum (Fig. 4) . This result indicates that the plasmid DNA (pLTR-DT) was protected from enzymatic attack by TMAG-liposome. In addition, this also suggests that the cationic TMAG-liposome may be efficient tool for gene transfer into the BLV-infected cells in vivo. Recently, it was reported that cationic liposomes can be utilized for DNA delivery into the cells in vivo [11, 14, 16] . Thus, the extension of the present studies to the nude mouse system is in progress.
In conclusion, transcription of the BLV p34 transactivator genes is essential for the expression of DT-A gene directed by BLV-LTR. It has been shown that transcription of the BLV genome is not detected in the tumor [7] . This suggests that pLTR-DT-containing TMAG-liposome may not be effective against the tumor cells of cattle with EBL.
However, Kono et al. have reported that transcription of BLV genes increases in parallel with development of persistent lymphocytosis (PL) [8] . Thus, PL which is thought to be an early stage of EBL is one of the candidates for the delivery of the DT-A gene into BLV-infected cells by the use of cationic liposomes. Furthermore, EBL caused by BLV is a B-cell lymphoma. It is well known that lymphoid cells are resistant to transfection [10, 21] . In our separate experiment, however, we found that cationic TMAG-liposome was able to transfect plasmid DNA not only into the adherent cells but also into the myeloma cells (manuscript in preparation). In this study, the possibility of DT-A gene delivery in vivo to the BLV-infected cells with cationic liposomes was also revealed. It is, therefore, possible that the present strategy can be applied to BLVinfected B-lymphocytes in vivo. In order to reveal the usefulness of TMAG-liposome containing pLTR-DT in the gene therapy of EBL, in vitro and in vivo study on the therapeutic effect of such liposomes against the bovine lymphoid cell lines established from a tumor of cattle with EBL is in progress. Moreover, the present data will also be useful for the research of gene delivery to certain cells in vitro and in vivo.
